Insulin and insulin-like growth factor-I promotes angiotensinogen production and growth in vascular smooth muscle cells

Journal of Hypertension

Volumn 18, Issue 8, 2000, Pages 1051-1056

  Kamide, Kei ^a,b   Hori, Mark T ^a,b   Zhu, Jian Hua ^a,b   Takagawa, Yoshitoki ^a,b   Barrett, Jack D ^a,b   Eggena, Peter ^a,b   Tuck, Michael L ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Angiotensinogen; IGF I; Insulin; Vascular smooth muscle

Indexed keywords

ANGIOTENSINOGEN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; MONOCLONAL ANTIBODY; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR SMOOTH MUSCLE;

EID: 0033851606     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018080-00009     Document Type: Article

References (33)

1. Role of insulin resistance in human disease
2. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglycemia, and hypertension
3. Insulin resistance. A multifaced syndrome for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
4. Insulin resistance and cardiovascular complications in patients with essential hypertension
5. Hyperinsulinemia as an independent risk factor for ischemic heart disease
6. Insulin resistance is related to silent cerebral infarction in patients with essential hypertension
7. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells
8. Insulin as a mitogenic factor: Role in the pathogenesis of cardiovascular disease
9. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I
10. Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subjects
11. Insulin-like growth factor I and its binding proteins in the cardiovascular system
12. Insulin-like growth factor I receptor: Structure, signal transduction, and function
13. Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: Effects of angiotensin converting enzyme inhibition
14. Serum total IGF-I, free IGF-I, and IGFBP-I levels in an elderly population. Relation to cardiovascular risk factors and diseases
15. Insulin regulation of IGF-I expression in rat aorta
16. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit
17. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits
18. Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system
19. AT1 receptor density changes during development of hypertension in hyperinsulinemic rats
20. Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells
21. Monoclonal antibodies to receptors for insulin and somatomedin C
22. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension
23. Insulin resistance in essential hypertension
24. The pathophysiology of hypertension. The importance of angiotensin II in cardiovascular remodeling
25. Regulation of insulin-like growth factor I gene expression. Implications for normal and pathological growth
26. Insulin-like growth factor and sodium-lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy
27. Relation of circulating insulin and insulin-like growth factor I to cardiovascular complications in patients with essential hypertension
28. Insulin response to oral glucose in essential hypertension with increased circulating levels of IGF-I
29. Insulin-like growth factor 1 and pressure load in hypertensive patients
30. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependent diabetes and hypertension
31. Effects of an angiotensin-converting enzyme, ramipril, on cardiovascular events in high-risk patients
32. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor
33. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension